- Home
- DTST vs LSTA Comparison
DTST vs LSTA Comparison
Compare DTST & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- LSTA
- Stock Information
- Founded
- DTST 2001
- LSTA 1980
- Country
- DTST United States
- LSTA United States
- Employees
- DTST N/A
- LSTA N/A
- Industry
- DTST EDP Services
- LSTA Misc Health and Biotechnology Services
- Sector
- DTST Technology
- LSTA Health Care
- Exchange
- DTST Nasdaq
- LSTA Nasdaq
- Market Cap
- DTST 32.7M
- LSTA 31.2M
- IPO Year
- DTST N/A
- LSTA N/A
- Fundamental
- Price
- DTST $4.22
- LSTA $2.61
- Analyst Decision
- DTST
- LSTA Strong Buy
- Analyst Count
- DTST 0
- LSTA 1
- Target Price
- DTST N/A
- LSTA $15.00
- AVG Volume (30 Days)
- DTST 50.4K
- LSTA 66.3K
- Earning Date
- DTST 03-27-2025
- LSTA 02-27-2025
- Dividend Yield
- DTST N/A
- LSTA N/A
- EPS Growth
- DTST N/A
- LSTA N/A
- EPS
- DTST 0.02
- LSTA N/A
- Revenue
- DTST $25,143,911.00
- LSTA N/A
- Revenue This Year
- DTST $2.57
- LSTA N/A
- Revenue Next Year
- DTST $11.16
- LSTA N/A
- P/E Ratio
- DTST $210.12
- LSTA N/A
- Revenue Growth
- DTST 1.64
- LSTA N/A
- 52 Week Low
- DTST $3.24
- LSTA $2.19
- 52 Week High
- DTST $8.00
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- DTST 44.52
- LSTA 42.17
- Support Level
- DTST $4.23
- LSTA $2.45
- Resistance Level
- DTST $4.49
- LSTA $2.74
- Average True Range (ATR)
- DTST 0.25
- LSTA 0.32
- MACD
- DTST -0.04
- LSTA -0.05
- Stochastic Oscillator
- DTST 7.69
- LSTA 16.48
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.